Antibodies : Impact Factor & More
eISSN: 2073-4468pISSN: 2073-4468
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Antibodies
Antibodies Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | Multidisciplinary Digital Publishing Institute (MDPI) |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | CHF 1600 |
| Publication Time | 6 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 6 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Antibodies ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Antibodies
Ca13Mab-17, a Novel Anti-Cadherin-13 Monoclonal Antibody for Versatile Applications
- 11 May 2026
- Antibodies
A Recombinant Antibody Against Human DRP1 Serine 616 Phosphorylation Enables Detection of BRAFV600E-Associated Mitochondrial Division in Cancer
- 20 Apr 2026
- Antibodies
Brain Delivery of Antibody-Derived Biologicals for Alzheimer\u2019s Disease: An Updated Narrative Review
- 17 Apr 2026
- Antibodies
Post-Chemotherapy Antibody-Based Continuation and Maintenance Strategies in HER2-Positive Metastatic Breast Cancer: A Translational Narrative Review.
- 16 Apr 2026
- Antibodies (Basel, Switzerland)
IMGT® Nomenclature of Immunoglobulins (IG) or Antibodies and T Cell Receptors (TR): A Common Language for Immunoinformatics and Artificial Intelligence (AI).
- 15 Apr 2026
- Antibodies (Basel, Switzerland)
Development of a Human IgG1 Monoclonal Antibody Targeting Transferrin Receptor 1 for Antitumor Drug Delivery.
- 13 Apr 2026
- Antibodies (Basel, Switzerland)
Ca13Mab-17, a Novel Anti-Cadherin-13 Monoclonal Antibody for Versatile Applications
- 11 May 2026
- Antibodies
A Recombinant Antibody Against Human DRP1 Serine 616 Phosphorylation Enables Detection of BRAFV600E-Associated Mitochondrial Division in Cancer
- 20 Apr 2026
- Antibodies
Brain Delivery of Antibody-Derived Biologicals for Alzheimer\u2019s Disease: An Updated Narrative Review
- 17 Apr 2026
- Antibodies
Post-Chemotherapy Antibody-Based Continuation and Maintenance Strategies in HER2-Positive Metastatic Breast Cancer: A Translational Narrative Review.
- 16 Apr 2026
- Antibodies (Basel, Switzerland)
IMGT® Nomenclature of Immunoglobulins (IG) or Antibodies and T Cell Receptors (TR): A Common Language for Immunoinformatics and Artificial Intelligence (AI).
- 15 Apr 2026
- Antibodies (Basel, Switzerland)
Development of a Human IgG1 Monoclonal Antibody Targeting Transferrin Receptor 1 for Antitumor Drug Delivery.
- 13 Apr 2026
- Antibodies (Basel, Switzerland)
FAQs on Antibodies
How long has Antibodies been actively publishing? 
What is the publishing frequency of Antibodies?
How many articles did Antibodies publish last year?
What is the eISSN & pISSN for Antibodies?
Who is the publisher of Antibodies?
